692 related articles for article (PubMed ID: 12082612)
1. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
2. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
3. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
Takeda A; Goolsby C; Yaseen NR
Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636
[TBL] [Abstract][Full Text] [Related]
4. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia.
Calvo KR; Knoepfler PS; Sykes DB; Pasillas MP; Kamps MP
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13120-5. PubMed ID: 11687616
[TBL] [Abstract][Full Text] [Related]
5. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
[TBL] [Abstract][Full Text] [Related]
6. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
Hirose K; Abramovich C; Argiropoulos B; Humphries RK
Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation.
Chung KY; Morrone G; Schuringa JJ; Plasilova M; Shieh JH; Zhang Y; Zhou P; Moore MA
Cancer Res; 2006 Dec; 66(24):11781-91. PubMed ID: 17178874
[TBL] [Abstract][Full Text] [Related]
8. NUP98 dysregulation in myeloid leukemogenesis.
Moore MA; Chung KY; Plasilova M; Schuringa JJ; Shieh JH; Zhou P; Morrone G
Ann N Y Acad Sci; 2007 Jun; 1106():114-42. PubMed ID: 17442773
[TBL] [Abstract][Full Text] [Related]
9. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.
Kamps MP; Wright DD
Oncogene; 1994 Nov; 9(11):3159-66. PubMed ID: 7936638
[TBL] [Abstract][Full Text] [Related]
10. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
11. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
[TBL] [Abstract][Full Text] [Related]
12. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
[TBL] [Abstract][Full Text] [Related]
13. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
Bourette RP; Grasset MF; Mouchiroud G
Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
[TBL] [Abstract][Full Text] [Related]
14. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.
Calvo KR; Sykes DB; Pasillas M; Kamps MP
Mol Cell Biol; 2000 May; 20(9):3274-85. PubMed ID: 10757811
[TBL] [Abstract][Full Text] [Related]
15. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
Wang GG; Pasillas MP; Kamps MP
Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
[TBL] [Abstract][Full Text] [Related]
16. A distinct epigenetic signature at targets of a leukemia protein.
Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
[TBL] [Abstract][Full Text] [Related]
17. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
18. [HUP98-HOXA9 transgenic mice are susceptible to N-ethyl-N-nitrosourea stimulation in leukemogenesis].
Lu SY; Gu MM; Wang Y; Tan Y; Sun YP; Wang L; Kong H; Lu ZY; Wang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):257-61. PubMed ID: 15182530
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells.
Hara T; Schwieger M; Kazama R; Okamoto S; Minehata K; Ziegler M; Löhler J; Stocking C
Oncogene; 2008 Jun; 27(27):3865-9. PubMed ID: 18223676
[TBL] [Abstract][Full Text] [Related]
20. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b.
Kroon E; Krosl J; Thorsteinsdottir U; Baban S; Buchberg AM; Sauvageau G
EMBO J; 1998 Jul; 17(13):3714-25. PubMed ID: 9649441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]